ANALYSIS OF GLIOMA CELL-LINES FOR AMPLIFICATION AND OVEREXPRESSION OF MDM2

被引:57
作者
HE, J
REIFENBERGER, G
LIU, L
COLLINS, VP
JAMES, CD
机构
[1] EMORY UNIV,SCH MED,DEPT NEUROSURG,MOLEC NEUROONCOL LAB,ATLANTA,GA 30322
[2] KAROLINSKA HOSP,LUDWIG INST CANC RES,S-10401 STOCKHOLM,SWEDEN
[3] KAROLINSKA HOSP,DEPT PATHOL,S-10401 STOCKHOLM,SWEDEN
关键词
D O I
10.1002/gcc.2870110205
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, amplification of the gene encoding a p53 binding protein, MDM2, was determined in 8% of the cases constituting a large series of glioblastomas. Here we have utilized Southern blot analysis to examine 30 cell lines established from such tumors, and our investigation has revealed large increases in MDM2 gene dosage in two cases, one of which showed coamplification of the CDK4 gene that resides in close proximity to MDM2 in chromosomal region 12q13-14. Northern analysis demonstrated overexpression of MDM2 mRNA in the two cell lines with gene amplification, and overexpression of MDM2 protein was evident in each of these by immunohistochemical and Western blot analysis. Analysis of TP53 cDNAs revealed normal TP53 sequences in the cell lines with MDM2 amplification; these results are consistent with those of previous studies suggesting that MDM2 amplification occurs only in tumors expressing wild-type p53. In total, these data suggest that MDM2 amplification in glioblastoma cell lines occurs at a frequency (6.7%) comparable to that determined in primary tumors; occurs in cell lines expressing wild-type p53; and can involve the coamplification of additional genes. Genes Chromosom Cancer 11:91-96 (1994). (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 24 条
  • [1] AMPLIFICATION OF THE HUMAN PUTATIVE ONCOGENE INT1 IN PRIMARY RETINOBLASTOMA TUMORS
    ARHEDEN, K
    TOMMERUP, N
    MANDAHL, N
    HEIM, S
    WINTHER, J
    JENSEN, OA
    PRAUSE, JU
    MITELMAN, F
    [J]. CYTOGENETICS AND CELL GENETICS, 1988, 48 (03): : 174 - 177
  • [2] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [3] TP53 GENE-MUTATIONS AND 17P DELETIONS IN HUMAN ASTROCYTOMAS
    CHUNG, R
    WHALEY, J
    KLEY, N
    ANDERSON, K
    LOUIS, DN
    MENON, A
    HETTLICH, C
    FREIMAN, R
    HEDLEYWHYTE, ET
    MARTUZA, R
    JENKINS, R
    YANDELL, D
    SEIZINGER, BR
    [J]. GENES CHROMOSOMES & CANCER, 1991, 3 (05) : 323 - 331
  • [4] EKSTRAND AJ, 1991, CANCER RES, V51, P2164
  • [5] A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY
    FEINBERG, AP
    VOGELSTEIN, B
    [J]. ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) : 6 - 13
  • [6] FORUS A, 1993, CELL GROWTH DIFFER, V4, P1065
  • [7] FRANKEL RH, 1992, CANCER RES, V52, P1427
  • [8] FULTS D, 1992, CANCER RES, V52, P674
  • [9] JAMES CD, 1993, CANCER RES, V53, P3674
  • [10] KHATIB ZA, 1993, CANCER RES, V53, P5535